JB Pharma Q4 Results: Net profit jumps 43% YoY to Rs 126 crore indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals & Pharmaceuticals said in a regulatory filing.
JB Chemicals & Pharmaceuticals on Wednesday received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market. The company s product is the generic version of Pfizer s Sinequan capsules which are indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.